PPCM
GEVA

Pillar Pacific Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Pillar Pacific Capital Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,550
Closed -$346K – 302
2015
Q1 		$346K Sell
3,550
-250
-7% -$26.5K 0.06% 192
2014
Q4 		$352K Hold
3,800
– – 0.06% 186
2014
Q3 		$262K Buy
+3,800
New +$272K 0.05% 231

Pillar Pacific Capital Management's GEVA Position: Q2 2015 in Review

Pillar Pacific Capital Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,550 shares — an estimated $346K sold.

Pillar Pacific Capital Management first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $352K in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Pillar Pacific Capital Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Pillar Pacific Capital Management sold 3,550 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $346K.
  • Pillar Pacific Capital Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Pillar Pacific Capital Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $352K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Pillar Pacific Capital Management's 13F filing for Q2 2015, filed 30 Jul 2015.